MARATTO

article · National Journal of Medical Research

Pre-Vaccination Profiles and Factors Associated with Suspected COVID-19 Infection in Vaccine Candidates in The Democratic Republic of Congo: A Cross-Sectional Study

Abstract

Background: The aim of this study was a pre-vaccination profile assessment to identify risks for adverse events. Methods: Cross-sectional, analytical study including 1,500 individuals presenting for COVID-19 vaccination at the Cliniques Universitaires de Kinshasa between April 19 and December 31, 2021. Results: Of 1500 individuals examined, 69.3% were male (sex ratio 3H/1F), mean age 47.5±16.0 years. A significant inverse relationship was observed between age and AST on the one hand (p=0.015); and age and ALT on the other (p=0.011). The correlation was 46.3% for AST and 46.9% for ALT. A total of 9.5% of individuals presenting for vaccination had an NLR greater than or equal to 2, signifying a COVID-19 infection. Female gender (aOR: 2.94 IC95%: 1.99-3.96), the presence of comorbidity (aOR: 2.83; 95%CI: 1.88-3.88), the presence of abnormal PAL (aOR: 2.12; 95%CI: 1.24-3.62) and the presence of abnormal RBC (aOR: 1.92; 95%CI: 1.22-3.01) were the factors independently associated with the COVID-19 infection in the study population. Conclusion: The results show a normal biological profile, but they highlight the importance of certain simple biological markers in screening for COVID-19 infection in an asymptomatic population.

Research topics

  • Vaccine Coverage and Hesitancy
  • COVID-19 epidemiological studies
  • SARS-CoV-2 and COVID-19 Research

Read the original research

This page summarises published work. The authoritative version sits with the publisher.

DOI: 10.55489/njmr.150420251201

Is something wrong with this record? Report it or request removal.

Discussion

Discuss this research

Have you built on this work, tried to replicate it, or seen it applied in practice? Share what you know. Verified researchers and MARATTO™ domain experts can open a discussion, and any member can reply. Contributions are reviewed before they appear.

No discussion yet. Open the first thread.